TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006
TCL Archive In Brief: Schmidt Advises Upton To Consider Moving Control Projects In Other Division To DCCR December 2, 1977
TCL Archive Bypass Budget Omits Needless Words: Faster Progress to Cost $421 Million More March 29, 1996
TCL Archive In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative” August 11, 1989